dalteparin has been researched along with Gestational Hypertension in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rottenstreich, A | 1 |
| Gershgoren, H | 1 |
| Spectre, G | 1 |
| Da'as, N | 1 |
| Bentur, OS | 1 |
| Levin, G | 1 |
| Kalish, Y | 1 |
1 other study available for dalteparin and Gestational Hypertension
| Article | Year |
|---|---|
Factors associated with pregnancy outcomes in women with a history of cerebral sinus venous thrombosis.
Topics: Abortion, Spontaneous; Abruptio Placentae; Adult; Anticoagulants; Case-Control Studies; Enoxaparin; | 2020 |